IgA anti-citrullinated protein antibodies (IgA ACPA) are associated with flares during DMARD tapering in rheumatoid arthritis.

Maria V SokolovaMelanie HagenHolger BangGeorg SchettJuergen RechUlrike Steffennull null

Published in: Rheumatology (Oxford, England) (2021)

In this study, IgA ACPA was identified as a risk factor for flare in combination with IgG ACPA. IgA2 ACPA levels were associated with flare severity and declined in patients in stable remission.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
disease activity
chronic kidney disease
prognostic factors
patient reported outcomes
systemic sclerosis
ulcerative colitis